Financials BioFish Holding

Equities

BFISH

NO0010955198

Fishing & Farming

Market Closed - Oslo Bors 10:45:00 2024-05-24 EDT 5-day change 1st Jan Change
1.24 NOK +5.08% Intraday chart for BioFish Holding +4.20% -11.43%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 193.5 80.4 126.2 126.2 -
Enterprise Value (EV) 1 193.5 80.4 123.7 98.15 85.15
P/E ratio - - -9.54 x -20.7 x 10.3 x
Yield - - - - -
Capitalization / Revenue 10.6 x 3.97 x 2.59 x 1.8 x 0.98 x
EV / Revenue 10.6 x 3.97 x 2.59 x 1.4 x 0.66 x
EV / EBITDA -28.6 x - -31.7 x 8.92 x 1.94 x
EV / FCF - - -2.79 x -3.78 x 6.55 x
FCF Yield - - -35.9% -26.5% 15.3%
Price to Book - - 0.54 x 0.78 x 0.69 x
Nbr of stocks (in thousands) 13,400 13,400 101,735 101,735 -
Reference price 2 14.44 6.000 1.240 1.240 1.240
Announcement Date 5/31/22 5/30/23 3/22/24 - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 18.33 20.24 47.68 70 129
EBITDA 1 -6.755 - -3.906 11 44
EBIT 1 -7.155 - -10.16 -1 32
Operating Margin -39.04% - -21.3% -1.43% 24.81%
Earnings before Tax (EBT) 1 - - -12.32 -6 29
Net income 1 - -14.89 -12.01 -7 22
Net margin - -73.56% -25.19% -10% 17.05%
EPS 2 - - -0.1300 -0.0600 0.1200
Free Cash Flow 1 - - -61 -26 13
FCF margin - - -127.08% -37.14% 10.08%
FCF Conversion (EBITDA) - - - - 29.55%
FCF Conversion (Net income) - - - - 59.09%
Dividend per Share - - - - -
Announcement Date 5/31/22 5/30/23 3/22/24 - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2022 Q1 2022 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7.681 1.98 1.98 27.58 - 17.19 3.2 27 27
EBITDA 1 - -6.32 -6.32 - -8.517 -0.831 -5 7 7
EBIT 1 - -6.92 -6.92 - -11.52 -2.282 -8 4 4
Operating Margin - -349.49% -349.49% - - -13.28% -250% 14.81% 14.81%
Earnings before Tax (EBT) 1 - -7.03 - - -13.11 -3.831 -9 3 3
Net income 1 - -7.03 - 8.083 -12.8 -3.831 -9 2 2
Net margin - -355.05% - 29.31% - -22.29% -281.25% 7.41% 7.41%
EPS 2 - - - - - - -0.0900 0.0100 0.0100
Dividend per Share - - - - - - - - -
Announcement Date 9/30/21 9/30/22 9/30/22 12/14/23 3/22/24 5/15/24 - - -
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt 1 - - 44 - -
Net Cash position 1 - - - 28 41
Leverage (Debt/EBITDA) - - -22 x - -
Free Cash Flow 1 - - -61 -26 13
ROE (net income / shareholders' equity) - - - - 9.5%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - - 2.300 1.600 1.800
Cash Flow per Share - - - - -
Capex 1 - - 43 12 12
Capex / Sales - - 89.58% 17.14% 9.3%
Announcement Date 5/31/22 5/30/23 3/22/24 - -
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.24 NOK
Average target price
2 NOK
Spread / Average Target
+61.29%
Consensus
  1. Stock Market
  2. Equities
  3. BFISH Stock
  4. Financials BioFish Holding